A Phase I clinical trial in healthy volunteers to evaluate a TRPC4/5 inhibitor.
Latest Information Update: 07 Nov 2017
At a glance
- Drugs BI 1358894 (Primary)
- Indications Anxiety disorders; CNS disorders; Depression
- Focus Adverse reactions
- 07 Nov 2017 New trial record